Document:

Exhibit
10.4.2

 

AMENDMENT NO. 2

TO

 

EMPLOYMENT AGREEMENT

 

AMENDMENT NO. 2
dated as of January 7, 2004 to an EMPLOYMENT
AGREEMENT entered into as of May 1, 1997 between Bio-Reference
Laboratories, Inc., a New Jersey corporation (“the Company”) and Sam Singer (“Employee”)
and previously amended as of November 1, 2002 by Amendment No. 1 (the
Employment Agreement and Amendment No. 1 collectively referred to as the “Agreement”).

 

WITNESSETH:

 

WHEREAS
the parties executed the Employment Agreement as of May 1, 1997 providing for
the employment by the Company of the Employee as Vice President and Chief
Financial Officer of the Company through October 31, 2002; and

 

WHEREAS pursuant to Amendment No. 1 executed as of November 1,
2002, the parties amended the Employment Agreement to extend the term
for two years, to grant the Company the option to extend the Agreement for up
to two additional consecutive one-year periods, to modify the compensation
terms and to effect other changes; and

 

WHEREAS the parties
hereby agree to amend the Agreement to extend the term for two additional years
and to grant the Company the option to renew the Agreement for an additional
year for the compensation and on the terms herein set forth:

 

NOW, THEREFORE,
in consideration of the premises and the mutual covenants contained herein and
intending to be legally bound hereby, the parties hereto agree to amend the
Agreement as follows:

 

C.                    “1. Terms of Employment.”
The “Expiration Date” as set forth in this section is extended to October 31,
2006.

 

D.                    “2. Renewal.” This section is
hereby amended to read in its entirety as follows:

 

“2. Renewal.
This Agreement will automatically renew for an additional one year period;
provided that the Company, at its sole option, may elect not to continue the
Agreement after the Expiration Date, by written notice to the Employee no less
than one (1) month before the Expiration Date.

 

C.                    “4. Compensation.”
The “Base Compensation” as set forth in paragraph (a) of this section in
each year of the extension period shall be not less than the salary and bonus
authorized for the Employee by the Company’s Compensation Committee with
respect to the Company’s 2002 fiscal year. In view of the possibility that
future payments of premiums by the Company under the “Split Dollar” Life
Insurance program referred to in paragraph (b) of this section could be
deemed an extension of credit prohibited by the Sarbanes- Oxley Act of 2002, it
is agreed that the program will be modified pursuant to an Endorsement
Split-Dollar Life Insurance Agreement in which the Company will be the owner of
the policies on terms which have been agreed to by the parties. The provisions
of paragraph (g) of this section concerning increases in Base Compensation
based upon percentage increases in the Consumer Price Index shall continue to
be applicable with respect to each year that the Agreement as extended
(including any renewal year if applicable) is in effect.

 

D.                    “5. Issuance
of Stock and Options.” This provision under the Agreement has been
fully satisfied in that the stock issued pursuant to paragraph (a) has been
issued to the Employee and is no longer forfeitable and the ISOs referred to in
paragraph (b) have also been issued to the Employee.

 

E.                      Other
Provisions. Except as specifically modified or amended herein, the parties
hereto hereby reaffirm each provision of the Agreement as of the date hereof.

 

F.                      Consideration.
In consideration for the Employee extending the Expiration Date of the
Agreement to October 31, 2006 and granting the Company the option to renew
the Agreement for an additional year to October 31, 2007, the Company
agrees to pay the sum of Sixty Thousand ($60,000) Dollars to the Employee.

 

IN WITNESS WHEREOF,
the undersigned have each duly executed this Amendment No. 2 to the Agreement
as of the date first above written.

 

 

	
   

  	
  COMPANY:

  
	
   

  	
   

  
	
   

  	
  Bio-Reference Laboratories, Inc.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By

  	
      /s/ Marc
  Grodman

  	
   

  
	
   

  	
   

  	
  Marc D. Grodman, President

  
	
   

  	
   

  	
  Duly Authorized

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  EMPLOYEE:

  
	
   

  	
   

  
	
   

  	
   

  	
  /s/ Sam Singer

  	
   

  
	
   

  	
   

  	
  Sam Singer

  
								

 

1Exhibit
10.12.1

 

ADDENDUM

TO

STRATEGIC
MARKETING ALLIANCE AGREEMENT

 

THIS ADDENDUM TO STRATEGIC MARKETING ALLIANCE
AGREEMENT (the “Addendum”) is entered into this 27th day of
December, 2004, by and among Roche Diagnostics Corporation, an Indiana
corporation, whose primary place of business is located at 9115 Hague Road,
Indianapolis, Indiana, 46250 (“RDC”), Bio-Reference Laboratories, Inc.,
a New Jersey corporation, whose primary place of business is located at 481B
Edward Ross Drive, Elmwood Park, New Jersey, 07407 (“BRLI”) and
CareEvolve.com, Inc., a New Jersey corporation, whose primary place of business
is located at 481B Edward Ross Drive, Elmwood Park, New Jersey, 07407 (“CareEvolve”).  (RDC, BRLI and CareEvolve are sometimes
referred to herein collectively as the “Parties” and each individually
as a “Party.”)

 

PRELIMINARY
STATEMENTS

 

A.            CareEvolve,
RDC and BRLI entered into that certain Strategic Marketing Alliance Agreement
dated as of December 31, 2001 (the “Original Agreement”), a copy of
which is attached hereto as Exhibit A and made a part hereof; and

 

B.            Pursuant
to the Original Agreement, the Parties created and participated in a strategic
marketing alliance (the “Alliance”).

 

C.            The
Parties now wish to modify the structure of the Alliance to, among other
things, reallocate responsibility for the provision of management services to
CareEvolve and alter the cost and expense structure between RDC and BRLI.

 

D.            To
those ends, the Parties wish to affirm portions of the Original Agreement,
amend other portions of the Original Agreement and supplement the Original
Agreement through this Addendum.

 

TERMS

 

NOW, THEREFORE, in consideration of the
mutual covenants herein contained and other good and valuable consideration,
the sufficiency of which is hereby acknowledged, the Parties, intending to be
legally bound, hereby agree as follows:

 

1.             Integration
with Original Agreement.  RDC and
BRLI hereby ratify, affirm and approve all terms and conditions of the Original
Agreement, unless the same are specifically amended, deleted, or supplemented
by this Addendum.  In the event of any
conflict between the terms of the Original Agreement and the terms of this
Addendum, the terms of this Addendum shall take precedence over the Original
Agreement, and this Addendum shall govern and control.  All references herein to the “Agreement”
shall mean the Original Agreement and this Addendum together.  All capitalized terms not otherwise defined
herein shall have the meanings assigned to them in the Original Agreement.

 

2.             Acknowledgement
of Continued Operation.  The Parties
hereby stipulate, acknowledge, understand and agree that CareEvolve has
operated in accordance with the direction and approval of the Steering
Committee and that the Alliance has developed into a business operation that
RDC and BRLI wish to continue developing and building as a joint effort.  The parties further agree that:

 

(a) All
obligations of RDC with respect to periods after August 31, 2003 imposed
by Section 2 of the original Agreement are hereby cancelled as of August 31,
2003.

 

(b) All
obligations of BRLI and CareEvolve with respect to periods after August 31,
2003 imposed by Section 3 and 4 of the Original Agreement are hereby
cancelled as of August 31, 2003.

 

(c) All
obligations of RDC, BRLI and CareEvolve with respect to periods after August 31,
2003 imposed by Section 5 of the Original Agreement are hereby cancelled
as of August 31, 2003.

 

(d) All rights
of RDC to a return of its invested capital, to a “revenue stream” and to a
license as set forth in Section 8(b) of the Original Agreement are hereby
cancelled nunc pro tunc as of October 31, 2004.

 

(e) All rights
of RDC to purchase equity interests in BRLI or CareEvolve as set forth in Section 15(a)
of the Original Agreement are hereby cancelled nunc pro tunc as of October 31,
2004.

 

1

 

(f) Each party
hereto hereby releases each and every other party hereto from any and all
liability for failure to perform any duty, effect any payment or fully meet any
obligation set forth in any of the above provisions of the Original Agreement
described in this Section 2 whether prior to or subsequent to August 31,
2003. The parties hereto agree that for all periods subsequent to August 31,
2003, the provisions of Section 5, 6, 7, 8 and 9 of this Addendum shall be
binding on each of them.

 

Representations
and Warranties of RDC. 
RDC hereby represents and warrants to BRLI as follows:

 

Authority;
Binding Agreement; Non-contravention.  RDC has full power and authority to execute
and deliver this Addendum and the other documents relating to the Alliance (the
“Alliance Documents”) and to perform its obligations hereunder and
thereunder.  This Addendum and the other
Alliance Documents, when executed, will constitute the valid and binding
obligation of RDC, enforceable in accordance with their respective terms.  Neither the execution and delivery of this
Addendum and the other Alliance Documents, nor the consummation of the actions
and transactions contemplated herein and therein will, with or without the
passage of time or the delivery of notice, (i) conflict with, result in a
breach or constitute a default under any note, bond, mortgage, indenture,
license, franchise, permit, agreement, lease or other instrument or obligation
to which RDC is a party or bound, (ii) violate any statute, ordinance or law or
any rule, regulation, order, writ, injunction or decree of any court,
administrative agency, commission or other governmental entity or
instrumentality, or (iii) violate any provision of the Articles of
Incorporation, bylaws or other constituent documents of RDC.

 

Organization.  RDC is a corporation duly organized and
validly existing under the laws of the State of Indiana.

 

Consents.  No notice to, filing with or authorization,
consent or approval of any governmental entity or third party is necessary for
the consummation by RDC of the actions and transactions contemplated by this
Addendum and the other Alliance Documents.

 

Authorization.  All corporate action on the part of RDC and
its directors and its shareholders necessary for the authorization, execution,
delivery and performance by RDC of each Alliance Document and the consummation
of the actions and transactions contemplated therein has been taken.

 

Litigation.  There is no action, suit, proceeding or
investigation pending, or to RDC’s knowledge, currently threatened against RDC
that questions the validity of this Addendum or any other Alliance Document, or
the right of RDC to enter into such agreements, or to consummate the actions
and transactions contemplated hereby or thereby.

 

Representations
and Warranties of BRLI.  BRLI hereby represents and warrants to RDC as
follows:

 

Authority;
Binding Agreement; Non-contravention.  BRLI has full power and authority to execute
and deliver this Agreement and the other Alliance Documents and to perform its
obligations hereunder and thereunder. 
This agreement and the other Alliance Documents, when executed, will
constitute the valid and binding obligation of BRLI, enforceable in accordance
with their respective terms.  Neither the
execution and delivery of this Addendum and the other Alliance Documents, nor
the consummation of the actions and transactions contemplated herein and
therein will, with or without the passage of time or the delivery of notice,
(i) conflict with, result in a breach or constitute a default under any note,
bond, mortgage, indenture, license, franchise, permit, agreement, lease or
other instrument or obligation to which BRLI is a party or bound, (ii) violate
any statute, ordinance or law or any rule, regulation, order, writ, injunction
or decree of any court, administrative agency, commission or other governmental
entity or instrumentality, or (iii) violate any provision of the Articles of
Incorporation, bylaws or other constituent documents of BRLI.

 

Organization.  BRLI is a corporation duly organized, validly
existing and in good standing under the laws of the State of New Jersey.

 

Consents.  No notice to, filing with or authorization,
consent or approval of any governmental entity or third party is necessary for
the consummation by BRLI of the actions and transactions contemplated by this
Addendum and the other Alliance Documents.

 

Confirmation
of CareEvolve Representations and Warranties.  All representations and warranties made by
CareEvolve in this Addendum or any other Alliance Document are true, correct
and complete, and no such

 

2

 

representation or warranty contains any
untrue statement of a material fact, or omits a material fact necessary to make
the statements therein not misleading.

 

Authorization.  All corporate action on the part of BRLI and
its directors and its shareholders necessary for the authorization, execution,
delivery and performance by BRLI of each Alliance Document and the consummation
of the actions and transactions contemplated therein has been taken.

 

Litigation.  There is no action, suit, proceeding or
investigation pending, or to BRLI’s knowledge, currently threatened against
BRLI that questions the validity of this Addendum or any other Alliance
Document, or the right of BRLI to enter into such agreements, or to consummate
the actions and transactions contemplated hereby or thereby.

 

Representations
and Warranties of CareEvolve.  CareEvolve hereby represents and warrants to
RDC as follows:

 

Authority;
Binding Agreement; Non-contravention.  CareEvolve has full power and authority to
execute and deliver this Addendum and the other Alliance Documents and to
perform its obligations hereunder and thereunder.  This Addendum and the other Alliance
Documents, when executed, will constitute the valid and binding obligation of
CareEvolve, enforceable in accordance with their respective terms.  Neither the execution and delivery of this
Addendum and the other Alliance Documents, nor the consummation of the actions
and transactions contemplated herein and therein will, with or without the
passage of time or the delivery of notice, (i) conflict with, result in a
breach or constitute a default under any note, bond, mortgage, indenture,
license, franchise, permit, agreement, lease or other instrument or obligation
to which CareEvolve is a party or bound, (ii) violate any statute, ordinance or
law or any rule, regulation, order, writ, injunction or decree of any court,
administrative agency, commission or other governmental entity or
instrumentality, or (iii) violate any provision of the Articles of
Incorporation, bylaws or other constituent documents of CareEvolve.

 

Organization.  CareEvolve is a corporation duly organized,
validly existing and in good standing under the laws of the State of New
Jersey.

 

Consents.  No notice to, filing with or authorization,
consent or approval of any governmental entity or third party is necessary for
the consummation by CareEvolve of the actions and transactions contemplated by
this Addendum and the other Alliance Documents.

 

Authorization.  All corporate action on the part of
CareEvolve and its directors and its shareholders necessary for the
authorization, execution, delivery and performance by CareEvolve of each
Alliance Document and the consummation of the actions and transactions
contemplated therein has been taken.

 

Ownership of
Intellectual Property. 
CareEvolve has a license with BRLI to re-license all inventions (whether
patentable or unpatentable and whether or not reduced to practice),
improvements, patents, trademarks (registered and unregistered), service marks,
trade dress, trade names, mask works, domain names and URL’s, copyrights
(registered and unregistered) and other intellectual property used or useful in
connection with the CareEvolve Service and the development, marketing and sale
thereof (collectively, the “CareEvolve IP”).  No person has challenged or, to CareEvolve’s
knowledge, threatened to challenge the validity of or CareEvolve’s rights to
the CareEvolve IP.  No act or omission of
CareEvolve or BRLI, including, without limitation, the use, production,
marketing, licensing or sale of the CareEvolve Service generally, or the
CareEvolve IP specifically, violates, infringes or misappropriates, or has
violated, infringed or misappropriated, any intellectual property rights of any
other person or entity.

 

Subsidiaries.  CareEvolve does not presently own or control,
directly or indirectly, any interest in any other corporation, association or
other business entity.  CareEvolve is not
a participant in any joint venture, partnership or similar arrangement other
than the Alliance.

 

Payment of
Expenses.

 

The Parties, and all of them, stipulate,
understand and agree that all expenses and costs of operation of CareEvolve
have been fully funded through August 31, 2003 and that from and after September 1,
2003, BRLI and CareEvolve shall be responsible for the payment of all expenses
and costs of any kind whatsoever for the operation, administration, management
and maintenance of CareEvolve.  RDC has
previously contributed sums in excess of the sums required to be paid under the
terms of the Original Agreement.  In
consideration for RDC waiving its right (if any) to reimbursement of

 

3

 

any previous contributions, BRLI and
CareEvolve hereby agree that RDC shall have no further obligation to contribute
to any of the ongoing costs and expenses of CareEvolve from and after September 1,
2003.  Nothing in this section will
prevent RDC from making contributions of either a financial or other kind to
help out with the operations of CareEvolve, but such contributions will be
strictly voluntary in nature and of no material consequence to the further
terms and conditions of this Agreement. 
This section represents a material change in the relationship of
the parties.  BRLI shall be responsible
for any deficit that shall occur in the financial operations of CareEvolve from
and after September 1, 2003.

 

Steering
Committee Duties.

 

The parties agree that the Steering Committee
shall continue to exist for the purpose of providing joint planning, guidance
and support to CareEvolve.  However, the
Steering Committee shall meet only at such times and such places as shall be
mutually convenient to all parties rather than any formal schedule of
meetings.

 

Right of First
Refusal.

 

BRLI hereby grants RDC during the term of
this Agreement a right of first refusal to purchase CareEvolve from BRLI at substantially
the same price and upon substantially the same terms as any valid, reasonable
offer by a third party to purchase CareEvolve from BRLI which BRLI is willing
to accept.  BRLI shall promptly provide
to RDC written notice of any offer received from a third party to purchase
CareEvolve from BRLI that BRLI is willing to accept, which notice shall include
a detailed, complete description of the terms of the offer provided by such
third party.  RDC shall have thirty days
from the date of notice to exercise such right of first refusal by providing
written notice to BRLI of RDC’s intent to exercise its right of first refusal.

 

Exclusive
Arrangement with IVD Companies.

 

BRLI and CareEvolve agree that during the
term of this Agreement the CareEvolve IP will not be licensed to, co-marketed
by, distributed by, or otherwise be subject to in any marketing or distribution
agreement with any IVD (In Vitro Diagnostic) company other than RDC.  RDC shall have the right to unilaterally
waive this provision at its own discretion.

 

Term;
Termination.

 

Term.  In accordance with Original Agreement Section 6,
the Term of the Agreement commenced on the date of the Original Agreement and
shall continue for a period of five years following the date of the Original
Agreement, unless earlier terminated in accordance with Section 11(b).

 

Termination.  The Agreement (including the Original
Agreement and this Addendum) may be terminated:

 

(1)           Mutual
Agreement.  Immediately, upon the
mutual written agreement of the Parties;

 

(2)           Anniversary
Dates.  On the first or any
subsequent anniversary of the date of the Original Agreement, by any Party,
upon written notice to the other Parties provided at least thirty, but no more
than sixty, days prior to the applicable anniversary date; provided, however,
that any notice of termination provided by CareEvolve pursuant hereto must be
approved in advance by the Steering Committee;

 

(3)           Material
Breach.  Immediately, by a
non-breaching Party, upon written notice if a Party materially breaches the Original
Agreement or this Addendum or any other Alliance Document, and such breach is
not curable, or if such breach is curable, within the thirty-day period
following the provision of written notice of such breach to the breaching
Party, if such breach is not cured within the thirty-day period;

 

(4)           Bankruptcy.  Immediately, by any Party upon written
notice, if any other Party (i) becomes insolvent; (ii) makes an assignment for
the benefit of its creditors; (iii) seeks or obtains protection under the bankruptcy
laws of the United States or any state, whether voluntarily or involuntarily;
(iv) develops or has developed a plan of arrangement or compensation agreement
as a result of a general meeting of its creditors; (v) has appointed a
receiver, custodian, trustee or like officer to take possession of all or any
substantial part of its assets; (vi) has all or any substantial part of its
assets attached, executed or seized; or (vii) admits in writing its inability
to pay its debts as they mature;

 

(5)           Termination
of Reseller Agreement.  Immediately,
by RDC, if the MedUnite Reseller

 

4

 

Agreement attached as Exhibit A to the
Original Agreement expires or is terminated for any reason whatsoever, unless
the MedUnite Reseller Agreement is terminated as a direct result of the acts,
actions or failures to act on the part of RDC; and

 

(6)           Steering
Committee Deadlock.  Immediately, by
any Party, if the Steering Committee is unable to reach agreement on a material
business issue relating to the conduct of the business, and after submission of
the issue to management discussions in accordance with Original Agreement Section 15(c)
the Parties are unable to resolve the deadlock.

 

Indemnification
Provisions for the Benefit of BRLI and CareEvolve.  RDC shall indemnify, defend and hold harmless
BRLI and CareEvolve and their agents, shareholders, officers, directors,
affiliates, successors and assigns from and against any and all actions, suits,
proceedings, claims, demands, orders, damages, dues, penalties, fines, costs,
liabilities, obligations, losses, expenses and fees (including without
limitation attorneys’ fees and costs) (collectively, “Losses”) resulting
from (a) RDC’s breach of any representation, warranty or covenant contained in
this Addendum or any other Alliance Document, or (b) RDC’s gross negligence or
willful misconduct in the course of its performance of this Agreement or any
other Alliance Document.

 

Indemnification
Provisions for the Benefit of RDC.

 

As to BRLI:  BRLI shall indemnify, defend and hold
harmless RDC and its agents, shareholders, officers, directors, affiliates,
successors and assigns from and against any and all Losses resulting from (a)
BRLI’s or CareEvolve’s breach of any material representation, warranty or
covenant contained in this Addendum or any other Alliance Document, or (b) BRLI’s
or CareEvolve’s gross negligence or willful misconduct in the course of its
performance of this Addendum or any other Alliance Document.

 

As to
CareEvolve: 
CareEvolve shall indemnify, defend and hold harmless RDC and its agents,
shareholders, officers, directors, affiliates, successors and assigns from and
against any all Losses resulting from (a) CareEvolve’s breach of any material
representation, warranty or covenant contained in this Addendum or any other
Alliance Document, (b) CareEvolve’s gross negligence or willful misconduct in
the course of its performance of this Addendum or any other Alliance Document,
(c) any injuries or death to persons, damage to property or other losses or
liabilities whatsoever realized by a third party as a result of the marketing,
sale, use, misuse, administration, transmission or other operation of the
CareEvolve Service, and (d) any actual or alleged violation, infringement,
breach or misappropriation by CareEvolve of any third party intellectual
property rights caused or allegedly caused by CareEvolve’s marketing,
ownership, use, misuse, licensing, sale, commercialization or any other
utilization of the CareEvolve Service and/or the CareEvolve IP.

 

Miscellaneous.

 

Notice.  All notices, requests, demands, approvals,
consents and other communications under this Addendum shall be made in
accordance with Original Agreement Section 15(d).

 

Expenses.  Except as explicitly provided in Sections
14, 15 and 16(d) with respect to indemnification claims, each
Party shall bear its own expenses in connection with the negotiation, execution
and performance of this Addendum and the other Alliance Documents, including
without limitation legal fees and expenses.

 

Succession and
Assignment. 
This Addendum shall be binding upon and inure to the benefit of the
Parties named herein and their respective successors and permitted
assigns.  No Party may assign or delegate
this Addendum or any of its rights, interests or obligations hereunder without
the prior written approval of the other Parties.

 

Taxes, Duties
and Other Charges. 
Unless the same are expressly made part of the RDC Expenses, BRLI and
CareEvolve shall indemnify and hold harmless RDC from and against any sales,
use, gross receipts, value-added, excise, property or other tax, tariff, duty
or assessment (excluding income taxes incurred by RDC) and related interest and
penalties collected, levied or imposed by national governments, state or
provincial governments, local governments or any subdivision of the foregoing
and arising out of or related to the operations of CareEvolve.

 

Publicity.  No Party shall issue any press release nor
make any public announcement respecting the execution or the terms of this
Addendum or any other Alliance Document without the prior approval of the other
Parties.

 

5

 

Headings.  The section headings contained in this
Addendum are inserted for convenience only and shall not affect in any way the
meaning or interpretation of this Addendum.

 

Counterparts;
Facsimile Signatures. 
This Addendum may be executed in counterparts, each of which shall
constitute an original, and all of which together shall constitute one and the
same instrument.  Delivery by a Party of
executed counterparts of this Addendum by facsimile shall constitute execution
and delivery of such counterpart to the same extent as if such counterpart were
originally executed and delivered by such Party.

 

Severability.
 If any provision of this Addendum shall
be held invalid, illegal or unenforceable in any jurisdiction, such provision
shall be ineffective to the extent of such invalidity, illegality or
unenforceability, the validity, legality or enforceability of the other
provisions hereof shall not be affected thereby, and there shall be deemed
substituted for the provision at issue a valid and enforceable provision as
similar as possible to the provision at issue, all without affecting the
validity, legality or enforceability of such provision in any other
jurisdictions.

 

Amendment.  No provision of this Addendum may be changed,
waived, discharged or terminated orally, by telephone or by any means except by
an instrument in writing signed by the Party against whom enforcement of the
change, waiver, discharge or termination is sought and then the same shall be
effective only in the specific instance for which it is given.

 

Interpretation.  The Parties hereto acknowledge and agree that
this Addendum represents the product of negotiations conducted in good faith
and at arm’s-length and that this Addendum should not be interpreted in favor
of or against any Party because of such Party’s ability or inability to control
the drafting of this Addendum.

 

Entire
Agreement.  This
Addendum, along with the other Alliance Documents, contain the entire agreement
of the Parties relating to the matters addressed herein or therein, superseding
any and all prior agreements, whether written or oral, except as otherwise
provided in Section 1.

 

{Remainder
of Page Intentionally Left Blank}

 

6

 

IN WITNESS WHEREOF, this Addendum is entered
into as of the date first above written.

 

 

	
   

  	
  ROCHE DIAGNOSTICS CORPORATION

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /S/ Dick Alerman

  	
   

  
	
   

  	
   

  
	
   

  	
  Printed:

  	
  Dick Alerman

  	
   

  
	
   

  	
   

  
	
   

  	
  Its:

  	
  Senior Vice President and General Manager

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  BIO-REFERENCE LABORATORIES, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /S/ Richard L. Faherty

  	
   

  
	
   

  	
   

  
	
   

  	
  Printed:

  	
  Richard L. Faherty

  	
   

  
	
   

  	
   

  
	
   

  	
  Its:

  	
  Chief Information Officer

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  CAREEVOLVE.COM, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
  /S/ Richard L. Faherty

  	
   

  
	
   

  	
   

  
	
   

  	
  Printed:

  	
  Richard L. Faherty

  	
   

  
	
   

  	
   

  
	
   

  	
  Its:

  	
  Chief Executive Officer

  	
   

  
															

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}]]